PGE2promotes Ca2+-mediated epithelial barrier disruption through EP1and EP4receptors in Caco-2 cell monolayers
- 1 August 2010
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 299 (2) , C324-C334
- https://doi.org/10.1152/ajpcell.00397.2009
Abstract
We recently demonstrated that PGE2 induces the disruption of the intestinal epithelial barrier function. In the present study, our objectives were to study the role of PGE2 receptors (EP1–EP4) and the signaling pathways involved in this event. Paracellular permeability (PP) was assessed in differentiated Caco-2 cell cultures from d-mannitol fluxes and transepithelial electrical resistance (TER) in the presence of different PGE2 receptor agonists (carbacyclin, sulprostone, butaprost, ONO-AE1-259, ONO-AE-248, GR63799, and ONO-AE1-329) and antagonists (ONO-8711, SC-19220, AH-6809, ONO-AE3-240, ONO-AE3-208, and AH-23848). The results indicate that EP1 and EP4 but not EP2 and EP3 might be involved in PP regulation. These effects were mediated through PLC-inositol trisphosphate (IP3)-Ca2+ and cAMP-PKA signaling pathways, respectively. We also observed an increase in intracellular Ca2+ concentration ([Ca2+]i) strengthened by cAMP formation indicating a cross talk interaction of these two pathways. Moreover, the participation of a conventional PKC isoform was shown. The results also indicate that the increase in PP may be correlated with the redistribution of occludin, zona occludens 1 (ZO-1), and the perijunctional actin ring together with an increase in myosin light chain kinase activity. Although the disruption of epithelial barrier function observed in inflammatory bowel disease (IBD) patients has been traditionally attributed to cytokines, the present study focused on the role of PGE2 in PP regulation, as mucosal levels of this eicosanoid are also increased in these inflammatory processes.Keywords
This publication has 57 references indexed in Scilit:
- Prostaglandin E2 couples through EP4 prostanoid receptors to induce IL‐8 production in human colonic epithelial cell linesBritish Journal of Pharmacology, 2009
- Role of cAMP in the promotion of colorectal cancer cell growth by Prostaglandin E2BMC Cancer, 2008
- Prostaglandin E2-EP1 and EP2 receptor signaling promotes apical junctional complex disassembly of Caco-2 human colorectal cancer cellsBMC Cell Biology, 2008
- Regulation of single inositol 1,4,5‐trisphosphate receptor channel activity by protein kinase A phosphorylationThe Journal of Physiology, 2008
- cAMP potentiates InsP3-induced Ca2+ release from the endoplasmic reticulum in blowfly salivary glandsBMC Physiology, 2008
- LIGHT Signals Directly to Intestinal Epithelia to Cause Barrier Dysfunction via Cytoskeletal and Endocytic MechanismsGastroenterology, 2007
- Molecular Basis of Epithelial Barrier RegulationThe American Journal of Pathology, 2006
- Prostaglandin E2receptor distribution and function in the gastrointestinal tractBritish Journal of Pharmacology, 2006
- HIV-1 gp120 Compromises Blood–Brain Barrier Integrity and Enhance Monocyte Migration across Blood–Brain Barrier: Implication for Viral NeuropathogenesisJournal of Cerebral Blood Flow & Metabolism, 2006
- Pharmacological characterization of [3H]‐prostaglandin E2 binding to the cloned human EP4 prostanoid receptorBritish Journal of Pharmacology, 2000